Thanissara Chansakul MD, Presenter: Nothing to Disclose

David M. Jackman, Abstract Co-Author: Consultant, F. Hoffmann-La Roche Ltd Consultant, Foundation Medicine, Inc

Rachna Madan MD, Abstract Co-Author: Nothing to Disclose

Patients with known primary thoracic malignancy or metastatic disease involving the thorax often experience urgent or emergent complications that are either a direct result of the underlying tumor or an indirect result related to therapy. A number of novel chemotherapeutic agents are associated with unique thoracic complications. Complications are often first identified on imaging studies. Awareness of such complications is crucial in order to minimize morbidity and mortality in oncologic patients.

Discuss potential urgent and emergent thoracic complications in oncologic patients. Highlight, using case-based approach, the clinical presentations and imaging findings of thoracic oncologic emergencies. Particular focus is placed on cases in which imaging plays a significant role in diagnosis and guiding clinical management. Well known urgent complications such as superior vena cava obstruction, pericardial tamponade, tumoral rupture and hemorrhage, massive hemoptysis as well as malignant airway obstruction due to central mass will be reviewed. Illustrate examples of emerging oncologic thoracic emergencies related to novel chemotherapeutic agents such as development of spontaneous pneumothoraces and intratumoral pseudoaneurysms with potential to rupture.

http://abstract.rsna.org/uploads/2014/14008954/14008954_747k.pdf

Chansakul, T, Jackman, D, Madan, R, Imaging of Classic and Emerging Thoracic Oncologic Emergencies.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14008954.html